SCHEMBL7140941

SCHEMBL7140941

O=C1Nc2c(Br)cc(Br)cc2C1=Cc1ccccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.43
MAX P61244 1/20 0.43
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
MAPK1 P28482 1/20 0.39
NTSR1 P30989 1/20 0.39
TNF P01375 2/20 0.39
IL6 P05231 1/20 0.39
CES1 P23141 1/20 0.39
NPC1 O15118 1/20 0.39
MEN1 O00255 2/20 0.37
RAB9A P51151 1/20 0.37
NOD1 Q9Y239 1/20 0.37
PLK4 O00444 1/20 0.36
PLK1 P53350 1/20 0.36
PTPN1 P18031 1/20 0.36
RAF1 P04049 1/20 0.36
CYP24A1 Q07973 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5362288 0.90 CES1 (0.39) MYCMAXKMT2AALDH1A1MAPT
SCHEMBL5367732 0.86 FLT3 (0.38) KMT2AALDH1A1MAPTXBP1MAPK1
SCHEMBL5365774 0.84 IKBKB (0.41) KMT2AALDH1A1MAPTXBP1MAPK1
SCHEMBL7139764 0.84 NPC1 (0.57) KMT2AALDH1A1MAPTXBP1MAPK1
SCHEMBL5358358 0.82 CES1 (0.39) KMT2AALDH1A1MAPTXBP1MAPK1
SCHEMBL7134869 0.81 SIRT1 (0.43) KMT2AALDH1A1MAPTXBP1MAPK1
SCHEMBL7139735 0.81 KMT2A (0.55) KMT2AALDH1A1MAPTXBP1MAPK1
SCHEMBL5362880 0.81 PLK4 (0.57) KMT2AALDH1A1MAPTXBP1MAPK1
SCHEMBL7133997 0.79 NPC1 (0.45) KMT2AALDH1A1MAPTXBP1MAPK1
SCHEMBL7140036 0.79 MYC (0.42) MYCMAXKMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed